Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Advances in radiotherapy for elderly patients with prostate cancer

Dr Lucinda Morris - St George Hospital Cancer Care Centre, Sydney, Australia

Advances in radiotherapy for elderly patients with prostate cancer ( Dr Lucinda Morris - St George Hospital Cancer Care Centre, Sydney, Australia )

PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced...

Prof Maha Hussain - Northwestern University Feinberg School of Medicine...

PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resistant prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )

TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of...

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinum-based regimens or immunotherapy ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration...

Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer ( Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands )

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer

Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of...

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer ( Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of Ireland )

Lutetium-177 PSMA scanning for prostate cancer

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

Lutetium-177 PSMA scanning for prostate cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President

Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )

Optimal timing of radiotherapy following radical prostatectomy

Prof Chris Parker - The Royal Marsden Hospital, London, UK

Optimal timing of radiotherapy following radical prostatectomy ( Prof Chris Parker - The Royal Marsden Hospital, London, UK )

Prostate cancer updates: Advances in precision medicine and PARP inhibitors

Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal

Prostate cancer updates: Advances in precision medicine and PARP inhibitors ( Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal )

Role of molecular diagnostics in prostate cancer

Dr Elena Castro and Dr Shahneen Sandhu

Role of molecular diagnostics in prostate cancer ( Dr Elena Castro and Dr Shahneen Sandhu )

IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer

Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain

IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer ( Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain )

Bladder cancer: Latest advances in targeted therapies and precision medicine...

Dr Javier Puente, Prof Maria De Santis, Dr Yohann Loriot, Dr Eva Comperat and...

Bladder cancer: Latest advances in targeted therapies and precision medicine from ESMO 2019 ( Dr Javier Puente, Prof Maria De Santis, Dr Yohann Loriot, Dr Eva Comperat and Dr Michiel Van der Heijden )

More from ecancer